Publications

Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.

Humphreys, GS; Merinopoulos, I; Ahmed, J; WHITTY, CJ M; Mutabingwa, TK; SUTHERLAND, CJ; Hallett, RL;

2006

Antimicrobial agents and chemotherapy, (2006).51 3 10.1128/AAC.00875-06.

Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole.

Prathalingham, SR; Wilkinson, SR; Horn, D; KELLY, JM;

2006

Antimicrobial agents and chemotherapy, (2006).51 2 10.1128/AAC.01360-06.

Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.

Gemma, S; Kukreja, G; Fattorusso, C; Persico, M; Romano, MP; Altarelli, M; Savini, L; Campiani, G; Fattorusso, E; Basilico, N; Taramelli, D; YARDLEY, V; Butini, S;

2006

Bioorganic & medicinal chemistry letters, (2006).16 20 10.1016/j.bmcl.2006.07.060.

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.

Swarthout, TD; Van den Broek, IV; Kayembe, G; Montgomery, J; Pota, H; ROPER, C;

2006

Tropical medicine & international health, (2006).11 10 10.1111/j.1365-3156.2006.01710.x.

Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal.

Laurent, T; Rijal, S; YARDLEY, V; CROFT, S; De Doncker, S; Decuypere, S; Khanal, B; Singh, R; Schönian, G; Kuhls, K; Chappuis, F; Dujardin, J-C;

2006

Infection, genetics and evolution, (2006).7 2 10.1016/j.meegid.2006.08.005.

Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal.

Ndiaye, D; Daily, JP; Sarr, O; Ndir, O; Gaye, O; Mboup, S; ROPER, C; Wirth, DF;

2006

Acta tropica, (2006).99 1 10.1016/j.actatropica.2006.07.002.

Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum.

Dunyo, S; Ord, R; Hallett, R; Jawara, M; Walraven, G; Mesa, E; Coleman, R; Sowe, M; ALEXANDER, N; TARGETT, GA T; Pinder, M; SUTHERLAND, CJ;

2006

PLoS clinical trials, (2006).1 3 10.1371/journal.pctr.0010014.

Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum.

Hallett, RL; Dunyo, S; Ord, R; Jawara, M; Pinder, M; Randall, A; Alloueche, A; Walraven, G; TARGETT, GA T; ALEXANDER, N; SUTHERLAND, CJ;

2006

PLoS clinical trials, (2006).1 3 10.1371/journal.pctr.0010015.

The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.

Sebaihia, M; WREN, BW; Mullany, P; Fairweather, NF; Minton, N; STABLER, R; THOMSON, NR; Roberts, AP; Cerdeño-Tárraga, AM; Wang, H; Holden, MT G; Wright, A; Churcher, C; Quail, MA; Baker, S; Bason, N; Brooks, K; Chillingworth, T; Cronin, A; Davis, P; Dowd, L; Fraser, A; Feltwell, T; Hance, Z; Holroyd, S; ... Parkhill, J.

2006

Nature genetics, (2006).38 7 10.1038/ng1830.

Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.

Alifrangis, M; Dalgaard, MB; Lusingu, JP; Vestergaard, LS; Staalsoe, T; Jensen, AT R; Enevold, A; Rønn, AM; Khalil, IF; WARHURST, DC; Lemnge, MM; Theander, TG; Bygbjerg, IC;

2006

The Journal of infectious diseases, (2006).193 12 10.1086/504269.